INIS
indonesia
78%
viruses
37%
patients
34%
populations
28%
antibodies
22%
genes
22%
covid-19
21%
doses
19%
vaccines
19%
levels
18%
diseases
15%
influenza viruses
15%
children
14%
comparative evaluations
14%
pneumonia
14%
data
14%
poultry
13%
influenza
12%
laboratories
12%
constipation
12%
hiv
12%
streptococcus
12%
sialic acid
11%
drugs
11%
proteins
11%
risks
10%
in vitro
10%
bacteria
10%
salmonella
10%
hospitals
9%
java
9%
safety
9%
women
9%
symptoms
8%
zika virus
8%
workers
8%
malaria
8%
dna
8%
mutations
8%
pcr
7%
clostridium perfringens
7%
fever
7%
chickens
7%
transmission
7%
antibiotics
7%
humans
7%
therapy
7%
administration
6%
receptors
6%
chains
6%
Keyphrases
Indonesia
100%
Jakarta
16%
COVID-19
16%
Indonesian
13%
Virus
13%
Sialidase
12%
Zika Virus
12%
Streptococcus Pneumoniae
12%
NanB
11%
North Sulawesi
9%
Pasteurella multocida
9%
H9N2 Avian Influenza Virus
9%
Avian Influenza
9%
Neu5Ac
9%
H9N2 Virus
8%
Poultry
8%
H5N1
8%
Neighbouring Area
8%
Cytomegalovirus
8%
HIV Patients
8%
Randomized Placebo-controlled Trial
8%
Functional Constipation
8%
Influenza A/H5N1 Virus
8%
Healthcare Workers
8%
Prospective Cohort Study
8%
Indonesian Population
8%
Single-center Study
8%
Subtype H9N2
7%
Virus Subtypes
7%
Arsenic
7%
Antiviral Activity
7%
Antibody Level
7%
S. Pneumoniae
7%
Pneumococcal Conjugate Vaccine
7%
SARS-CoV-2 Infection
6%
Sialic Acid
6%
H5N1 Virus
6%
Falciparum Malaria
6%
Disease Severity
6%
Quantitative PCR
6%
β-lactamase
5%
H9N2
5%
In Silico
5%
Heterologous Booster
5%
Older children
5%
4-year-olds
5%
Leukocytes
5%
South-East Asia
5%
Zika Virus Transmission
5%
Adult Patients
5%